1
|
Antibiotic-loaded hydroxyapatite scaffolds fabricated from Nile tilapia bones for orthopaedics. Int J Pharm X 2023; 5:100169. [PMID: 36861068 PMCID: PMC9969256 DOI: 10.1016/j.ijpx.2023.100169] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2022] [Revised: 02/01/2023] [Accepted: 02/05/2023] [Indexed: 02/11/2023] Open
Abstract
This work aimed to develop new antibiotic-coated/ antibiotic-loaded hydroxyapatite (HAp) scaffolds for orthopaedic trauma, specifically to treat the infection after fixation of skeletal fracture. The HAp scaffolds were fabricated from the Nile tilapia (Oreochromis niloticus) bones and fully characterized. The HAp scaffolds were coated with 12 formulations of poly (lactic-co-glycolic acid) (PLGA) or poly (lactic acid) (PLA), blended with vancomycin. The vancomycin release, surface morphology, antibacterial properties, and the cytocompatibility of the scaffolds were conducted. The HAp powder contains elements identical to those found in human bones. This HAp powder is suitable as a starting material to build scaffolds. After the scaffold fabrication, The ratio of HAp to β-TCP changed, and the phase transformation of β-TCP to α-TCP was observed. All antibiotic-coated/ antibiotic-loaded HAp scaffolds can release vancomycin into the phosphate-buffered saline (PBS) solution. PLGA-coated scaffolds obtained faster drug release profiles than PLA-coated scaffolds. The low polymer concentration in the coating solutions (20%w/v) gave a faster drug release profile than the high polymer concentration (40%w/v). All groups showed a trace of surface erosion after being submerged in PBS for 14 days. Most of the extracts can inhibit Staphylococcus aureus (S. aureus) and methicillin-resistant S. aureus (MRSA). The extracts not only caused no cytotoxicity to Saos-2 bone cells but also can increase cell growth. This study demonstrates that it is possible to use these antibiotic-coated/ antibiotic-loaded scaffolds in the clinic as an antibiotic bead replacement.
Collapse
Key Words
- Antibiotic
- Antibiotic-coated
- Antibiotic-loaded
- CLSI, The Clinical and Laboratory Standards Institute
- DI, Deionized water
- DMSO, Dimethyl sulfoxide
- F10[PLGA40-Hvanc], Formulation 10, HAp saffolds containing high concentration of vancomycin, coated with PLGA 40%w/v
- F11[PLA20-Hvanc], Formulation 11, HAp saffolds containing high concentration of vancomycin, coated with PLA 20%w/v
- F12[PLA40-Hvanc], Formulation 12, HAp saffolds containing high concentration of vancomycin, coated with PLA 40%w/v
- F1[V-PLGA20-Lvanc], Formulation 1, HAp saffolds containing low concentration of vancomycin, coated with PLGA 20%w/v blended with vancomycin
- F2[V-PLGA40-Lvanc], Formulation 2, HAp saffolds containing low concentration of vancomycin, coated with PLGA 40%w/v blended with vancomycin
- F3[V-PLA20-Lvanc], Formulation 3, HAp saffolds containing low concentration of vancomycin, coated with PLA 20%w/v blended with vancomycin
- F4[V-PLA40-Lvanc], Formulation 4, HAp saffolds containing low concentration of vancomycin, coated with PLA 40%w/v blended with vancomycin
- F5[PLGA20-Lvanc], Formulation 5, HAp saffolds containing low concentration of vancomycin, coated with PLGA 20%w/v
- F6[PLGA40-Lvanc], Formulation 6, HAp saffolds containing low concentration of vancomycin, coated with PLGA 40%w/v
- F7[PLA20-Lvanc], Formulation 7, HAp saffolds containing low concentration of vancomycin, coated with PLA 20%w/v
- F8[PLA40-Lvanc], Formulation 8, HAp saffolds containing low concentration of vancomycin, coated with PLA 40%w/v
- F9[PLGA20-Hvanc], Formulation 9, HAp saffolds containing high concentration of vancomycin, coated with PLGA 20%w/v
- FDA, Food and Drug Administration
- FTIR, Fourier transforms infrared spectroscopy
- HAp, Hydroxyapatite
- Hydroxyapatite
- IFSF, The infection after fixation of skeletal fracture
- Nile tilapia
- P.U., Polyurethane
- PBS, Phosphate-buffered saline
- PLA, Poly(lactic acid)
- PLGA, Poly(lactic-co-glycolic acid)
- PVA, Polyvinyl alcohol
- SEM, Scanning electron microscopy
- Scaffold
- Vancomycin
- XRD, X-ray diffraction
- XRF, X-ray fluorescence spectroscopy
- α-TCP, α-tricalcium phosphate
- β-TCP, β-tricalcium phosphate
Collapse
|
2
|
Structural and mechanical properties of Si-doped CrN coatings deposited by magnetron sputtering technique. Heliyon 2023; 9:e13461. [PMID: 36816227 PMCID: PMC9929308 DOI: 10.1016/j.heliyon.2023.e13461] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2022] [Revised: 01/25/2023] [Accepted: 01/31/2023] [Indexed: 02/05/2023] Open
Abstract
This study successfully deposited Si-doped CrN coatings onto Si (100) substrate by direct current magnetron sputtering. The concentration of Si in the CrSiN coatings was varied by changing the Si target current during deposition. The microstructural and mechanical properties were determined by employing X-ray diffraction, X-ray photoelectron spectroscopy, atomic force microscopy, and nanoindentation test. According to the results, the coating with 3.3 at.% Si contents (CrSiN-2) show an increase and decrease in the crystallite size and coating surface roughness, respectively, leading to solid solution hardening with an optimum hardness and elastic modulus of 21.37 GPa and 205.68 GPa, respectively. With continued Si addition, the coating roughness increased and the mechanical properties gradually decreased and attained 184.08 GPa and 18.95 GPa for the elastic modulus and hardness of the coating with a maximum Si concentration of 9.2 at.% (CrSiN-5).
Collapse
|
3
|
Extracellular vesicle-loaded hydrogels for tissue repair and regeneration. Mater Today Bio 2022; 18:100522. [PMID: 36593913 PMCID: PMC9803958 DOI: 10.1016/j.mtbio.2022.100522] [Citation(s) in RCA: 56] [Impact Index Per Article: 28.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2022] [Revised: 12/04/2022] [Accepted: 12/13/2022] [Indexed: 12/24/2022] Open
Abstract
Extracellular vesicles (EVs) are a collective term for nanoscale or microscale vesicles secreted by cells that play important biological roles. Mesenchymal stem cells are a class of cells with the potential for self-healing and multidirectional differentiation. In recent years, numerous studies have shown that EVs, especially those secreted by mesenchymal stem cells, can promote the repair and regeneration of various tissues and, thus, have significant potential in regenerative medicine. However, due to the rapid clearance capacity of the circulatory system, EVs are barely able to act persistently at specific sites for repair of target tissues. Hydrogels have good biocompatibility and loose and porous structural properties that allow them to serve as EV carriers, thereby prolonging the retention in certain specific areas and slowing the release of EVs. When EVs are needed to function at specific sites, the EV-loaded hydrogels can stand as an excellent approach. In this review, we first introduce the sources, roles, and extraction and characterization methods of EVs and describe their current application status. We then review the different types of hydrogels and discuss factors influencing their abilities to carry and release EVs. We summarize several strategies for loading EVs into hydrogels and characterizing EV-loaded hydrogels. Furthermore, we discuss application strategies for EV-loaded hydrogels and review their specific applications in tissue regeneration and repair. This article concludes with a summary of the current state of research on EV-loaded hydrogels and an outlook on future research directions, which we hope will provide promising ideas for researchers.
Collapse
Key Words
- 4-arm-PEG-MAL, four-armed polyethylene glycol (PEG) functionalized with maleimide group
- AD/CS/RSF, alginate-dopamine chondroitin sulfate and regenerated silk fibroin
- ADSC, Adipose derived mesenchymal stem cells
- ADSC-EVs, adipose mesenchymal stem cells derived EVs
- ADSC-Exos, adipose mesenchymal stem cells derived exosomes
- ATRP, Atom transfer radical polymerization
- BCA, bicinchoninic acid
- BMSC, Bone marrow mesenchymal stem cells
- BMSC-EVs, bone marrow mesenchymal stem cells derived EVs
- BMSC-Exos, bone marrow mesenchymal stem cells derived exosomes
- CGC, chitosan-gelatin-chondroitin sulfate
- CL, chitosan lactate
- CNS, central nervous system
- CPCs, cardiac progenitor cells
- CS-g-PEG, chitosan-g-PEG
- DPSC-Exos, dental pulp stem cells derived exosomes
- ECM, extracellular matrix
- EGF, epidermal growth factor
- EVMs, extracellular vesicles mimetics
- EVs, Extracellular vesicles
- Exos, Exosomes
- Exosome
- Extracellular vesicle
- FEEs, functionally engineered EVs
- FGF, fibroblast growth factor
- GelMA, Gelatin methacryloyl
- HA, Hyaluronic acid
- HAMA, Hyaluronic acid methacryloyl
- HG, nano-hydroxyapatite-gelatin
- HIF-1 α, hypoxia-inducible factor-1 α
- HS-HA, hypoxia-sensitive hyaluronic acid
- HUVEC, human umbilical vein endothelial cell
- Hydrogel
- LAP, Lithium Phenyl (2,4,6-trimethylbenzoyl) phosphinate
- LSCM, laser scanning confocal microscopy
- MC-CHO, Aldehyde methylcellulose
- MMP, matrix metalloproteinase
- MNs, microneedles
- MSC-EVs, mesenchymal stem cells derived EVs
- MSC-Exos, mesenchymal stem cells derived exosomes
- MSCs, mesenchymal stem cells
- NPCs, neural progenitor cells
- NTA, nanoparticle tracking analysis
- OHA, oxidized hyaluronic acid
- OSA, oxidized sodium alginate
- PDA, Polydopamine
- PDLLA, poly(D l-lactic acid)
- PDNPs-PELA, Polydopamine nanoparticles incorporated poly (ethylene glycol)-poly(ε-cap-rolactone-co-lactide)
- PEG, Polyethylene glycol
- PF-127, Pluronic F-127
- PHEMA, phenoxyethyl methacrylate
- PIC, photo-induced imine crosslinking
- PKA, protein kinase A system
- PLA, Poly lactic acid
- PLGA, polylactic acid-hydroxy acetic acid copolymer
- PLLA, poly(l-lactic acid)
- PPy, polypyrrole
- PVA, polyvinyl alcohol
- RDRP, Reversible deactivation radical polymerization
- Regeneration
- SCI, spinal cord injury
- SEM, Scanning electron microscopy
- SF, Silk fibroin
- SPT, single-particle tracking
- TEM, transmission electron microscopy
- Tissue repair
- UMSC, umbilical cord mesenchymal stem cells
- UMSC-EVs, umbilical cord mesenchymal stem cells derived EVs
- UMSC-Exos, umbilical cord mesenchymal stem cells derived exosomes
- UV, ultraviolet
- VEGF, vascular endothelial growth factor
- VEGF-R, vascular endothelial growth factor receptor
- WB, western blotting
- dECM, decellularized ECM
- hiPS-MSC-Exos, human induced pluripotent stem cell-MSC-derived exosomes
- iPS-CPCs, pluripotent stem cell-derived cardiac progenitors
- nHP, nanohydroxyapatite/poly-ε-caprolactone
- sEVs, small extracellular vesicles
- β-TCP, β-Tricalcium Phosphate
Collapse
|
4
|
Mycobacterium abscessus biofilms produce an extracellular matrix and have a distinct mycolic acid profile. Cell Surf 2021; 7:100051. [PMID: 33912773 PMCID: PMC8066798 DOI: 10.1016/j.tcsw.2021.100051] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2021] [Revised: 03/25/2021] [Accepted: 03/26/2021] [Indexed: 02/06/2023] Open
Abstract
A non-tuberculous mycobacterium, Mycobacterium abscessus is an emerging opportunistic pathogen associated with difficult to treat pulmonary infections, particularly in patients suffering from cystic fibrosis. It is capable of forming biofilms in vitro that result in an increase of already high levels of antibiotic resistance in this bacterium. Evidence that M. abscessus forms biofilm-like microcolonies in patient lungs and on medical devices further implicated the need to investigate this biofilm in detail. Therefore, in this study we characterized the M. abscessus pellicular biofilm, formed on a liquid-air interface, by studying its molecular composition, and its transcriptional profile in comparison to planktonic cells. Using scanning electron micrographs and fluorescence microscopy, we showed that M. abscessus biofilms produce an extracellular matrix composed of lipids, proteins, carbohydrates and extracellular DNA. Transcriptomic analysis of biofilms revealed an upregulation of pathways involved in the glyoxylate shunt, redox metabolism and mycolic acid biosynthesis. Genes involved in elongation and desaturation of mycolic acids were highly upregulated in biofilms and, mirroring those findings, biochemical analysis of mycolates revealed molecular changes and an increase in mycolic acid chain length. Together these results give us an insight into the complex structure of M. abscessus biofilms, the understanding of which may be adapted for clinical use in treatment of biofilm infections, including strategies for dispersing the extracellular matrix, allowing antibiotics to gain access to bacteria within the biofilm.
Collapse
|
5
|
Nanoparticles of cisplatin augment drug accumulations and inhibit multidrug resistance transporters in human glioblastoma cells. Saudi Pharm J 2021; 29:857-873. [PMID: 34408546 PMCID: PMC8363105 DOI: 10.1016/j.jsps.2021.07.001] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2021] [Accepted: 07/04/2021] [Indexed: 11/16/2022] Open
Abstract
Background Cisplatin (CSP) is a potent anticancer drug widely used in treating glioblastoma multiforme (GBM). However, CSP's clinical efficacy in GBM contrasted with low therapeutic ratio, toxicity, and multidrug resistance (MDR). Therefore, we have developed a system for the active targeting of cisplatin in GBM via cisplatin loaded polymeric nanoplatforms (CSP-NPs). Methods CSP-NPs were prepared by modified double emulsion and nanoprecipitation techniques. The physiochemical characterizations of CSP-NPs were performed using zeta sizer, scanning electron microscopy (SEM), drug release kinetics, and drug content analysis. Cytotoxicity, induction of apoptosis, and cell cycle-specific activity of CSP-NPs in human GBM cell lines were evaluated by MTT assay, fluorescent microscopy, and flow cytometry. Intracellular drug uptake was gauged by fluorescent imaging and flow cytometry. The potential of CSP-NPs to inhibit MDR transporters were assessed by flow cytometry-based drug efflux assays. Results CSP-NPs have smooth surface properties with discrete particle size with required zeta potential, polydispersity index, drug entrapment efficiency, and drug content. CSP-NPs has demonstrated an ‘initial burst effect’ followed by sustained drug release properties. CSP-NPs imparted dose and time-dependent cytotoxicity and triggered apoptosis in human GBM cells. Interestingly, CSP-NPs significantly increased uptake, internalization, and accumulations of anticancer drugs. Moreover, CSP-NPs significantly reversed the MDR transporters (ABCB1 and ABCG2) in human GBM cells. Conclusion The nanoparticulate system of cisplatin seems to has a promising potential for active targeting of cisplatin as an effective and specific therapeutic for human GBM, thus eliminating current chemotherapy's limitations.
Collapse
Key Words
- ABC, ATP-binding cassette
- ANOVA, Analysis of variance
- Active drug targeting
- BBB, Blood brain barrier
- BCRP, Breast cancer resistance protein
- CSP, Cisplatin
- CSP-NPs, Cisplatin nanoparticles DMEM, Dulbecco’s modified eagle medium
- Cisplatin nanoparticles
- DMSO, Dimethyl sulfoxide
- DNR, Daunorubicin
- DOX, Doxorubicin
- Drug uptake and accumulations
- EDTA, Ethylenediaminetetraacetic acid
- EPR, Enhanced permeability retention
- FACS, Fluorescence activated cell sorting
- FBS, Fetal bovine serum
- FTC, Fumitremorgin C
- GBM, Glioblastoma multiforme
- HBSS, Hank’s balanced salt solution
- HPLC, High Performance Liquid Chromatography
- Induction of Apoptosis
- MDR, Multidrug resistance
- MTT, Methyl tetrazolium
- MX, Mitoxantrone
- NPs, Nanoparticles
- O.D., Optical density
- PBS, Phosphate buffer saline
- PI, Propidium iodide
- PLGA, Poly (lactic-co-glycolic) acid
- RT, Room temperature
- Rho-123, Rhodamine 123
- SDS, Sodium dodecyl sulfate
- SEM, Scanning electron microscopy
- Targeting multidrug resistance (MDR) transporters
- nm, Nanometer
Collapse
|
6
|
In vitro susceptibility of human Blastocystis subtypes to simeprevir. Saudi J Biol Sci 2021; 28:2491-2501. [PMID: 33935570 PMCID: PMC8071969 DOI: 10.1016/j.sjbs.2021.01.050] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2020] [Revised: 01/19/2021] [Accepted: 01/21/2021] [Indexed: 11/19/2022] Open
Abstract
Introduction and aim Blastocystis is a common enteric parasite, having a worldwide distribution. Many antimicrobial agents are effective against it, yet side effects and drug resistance have been reported. Thus, ongoing trials are being conducted for exploring anti-Blastocystis alternatives. Proteases are attractive anti-protozoal drug targets, having documented roles in Blastocystis. Serine proteases are present in both hepatitis C virus and Blastocystis. Since drug repositioning is quite trendy, the in vitro efficacy of simeprevir (SMV), an anti-hepatitis serine protease inhibitor, against Blastocystis was investigated in the current study. Methods Stool samples were collected from patients, Alexandria, Egypt. Concentrated stools were screened using direct smears, trichrome, and modified Ziehl-Neelsen stains to exclude parasitic co-infections. Positive stool isolates were cultivated, molecularly subtyped for assessing the efficacy of three SMV doses (100,150, and 200 μg/ml) along 72 hours (h), on the most common subtype, through monitoring parasite growth, viability, re-culture, and also via ultrastructure verification. The most efficient dose and duration were later tested on other subtypes. Results Results revealed that Blastocystis was detected in 54.17% of examined samples. Molecularly, ST3 predominated (62%), followed by ST1 (8.6%) and ST2 (3.4%). Ascending concentrations of SMV progressively inhibited growth, viability, and re-culture of treated Blastocystis, with a non-statistically significant difference when compared to the therapeutic control metronidazole (MTZ). The most efficient dose and duration against ST3 was 150 µg/ml for 72 h. This dose inhibited the growth of ST3, ST1, and ST2 with percentages of 95.19%, 94.83%, and 94.74%, successively and viability with percentages of 98.30%, 98.09%, and 97.96%, successively. This dose abolished Blastocystis upon re-culturing. Ultra-structurally, SMV induced rupture of Blastocystis cell membrane leading to necrotic death, versus the reported apoptotic death caused by MTZ. In conclusion, 150 µg/ml SMV for 72 h proved its efficacy against ST1, ST2, and ST3 Blastocystis, thus sparing the need for pre-treatment molecular subtyping in developing countries.
Collapse
Key Words
- Blastocystis subtypes
- CV, central vacuole
- DMSO, Dimethyl Sulfoxide
- IBS, irritable bowel syndrome
- In vitro
- MLO, Mitochondrion-like organelle
- MTZ, Metronidazole
- PCR, Polymerase chain reaction
- Re-culture
- SEM, Scanning electron microscopy
- SMV, Simeprevir
- ST, subtypes
- Simeprevir
- TEM, Transmission electron microscopy
- Ultrastructure
- Viability
Collapse
|
7
|
Impact of nanoparticle inclusion on bioethanol production process kinetic and inhibitor profile. BIOTECHNOLOGY REPORTS (AMSTERDAM, NETHERLANDS) 2021; 29:e00585. [PMID: 33511040 PMCID: PMC7817428 DOI: 10.1016/j.btre.2021.e00585] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/03/2020] [Revised: 12/08/2020] [Accepted: 12/31/2020] [Indexed: 01/06/2023]
Abstract
NiO nanoparticle (NP) inclusion enhanced bioethanol production up to 59.96 %. Band energy gap impact NP catalytic performance in bioethanol production. NiO nanoparticle biocatalyst improved bioethanol productivity by 145 %. Modified Gompertz model was used to describe ethanol production with NP inclusion. Metallic NiO nanoparticles significantly reduced acetic acid concentration by 110 %.
This study examines the effects of nanoparticle inclusion in instantaneous saccharification and fermentation (NIISF) of waste potato peels. The effect of nanoparticle inclusion on the fermentation process was investigated at different stages which were: pre-treatment, liquefaction, saccharification and fermentation. Inclusion of NiO NPs at the pre-treatment stage gave a 1.60-fold increase and 2.10-fold reduction in bioethanol and acetic acid concentration respectively. Kinetic data on the bioethanol production fit the modified Gompertz model (R 2 > 0.98). The lowest production lag time (t L) of 1.56 h, and highest potential bioethanol concentration (P m) of 32 g/L were achieved with NiO NPs inclusion at different process stages; the liquefaction stage and the pre-treatment phase, respectively. Elevated bioethanol yield, coupled with substantial reduction in process inhibitors in the NIISF processes, demonstrated the significance of point of nanobiocatalysts inclusion for the scale-up development of bioethanol production from potato peels.
Collapse
Key Words
- ATP, Adenosine triphosphate
- Band energy gap
- Bioethanol
- EDS, Energy dispersive spectrophotometric
- EDX, Energy-dispersive X-ray spectroscopy
- GC–MS, Gas chromatography-Mass spectrometry
- HMF, 5-Hydroxymethyl Furfural
- ISF, Instant saccharification and fermentation
- Inhibitor profile
- NPs, Nanoparticles
- NSLIS, Nano + SATP + Liquefaction + SS + No Fermentation
- NSLISF, Nano + SATP + liquefaction + ISF
- Nanoparticles
- ORP, Oxidation–reduction potential
- SATP, Soaking assisted thermal pre-treatment
- SEM, Scanning electron microscopy
- SLIS, SATP + Liquefaction + SS + No Fermentation
- SLISF, SATP + Liquefaction + ISF
- SLNISF, SATP + Liquefaction + Nano + ISF
- SNLISF, SATP + Nano + Liquefaction + ISF
- SPA, Surface Plasmon Absorption
- SPR, Surface plasmon resonance
- Saccharomyces cerevisiae
- TEM, Transmission electron microscopy
- UV–vis, Ultraviolent visible
- VICs, Volatile inhibitory compounds
- wt%, Weight percent
Collapse
|
8
|
Biofilms of the non-tuberculous Mycobacterium chelonae form an extracellular matrix and display distinct expression patterns. Cell Surf 2020; 6:100043. [PMID: 32803022 PMCID: PMC7421604 DOI: 10.1016/j.tcsw.2020.100043] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2020] [Revised: 07/28/2020] [Accepted: 07/29/2020] [Indexed: 12/18/2022] Open
Abstract
Mycobacterium chelonae is an environmental, non-tuberculous mycobacterial species, capable of causing infections in humans. Biofilm formation is a key strategy used by M. chelonae in colonising niches in the environment and in the host. We studied a water-air interface (pellicle) biofilm of M. chelonae using a wide array of approaches to outline the molecular structure and composition of the biofilm. Scanning electron micrographs showed that M. chelonae biofilms produced an extracellular matrix. Using a combination of biochemical analysis, Raman spectroscopy, and fluorescence microscopy, we showed the matrix to consist of proteins, carbohydrates, lipids and eDNA. Glucose was the predominant sugar present in the biofilm matrix, and its relative abundance decreased in late (established) biofilms. RNA-seq analysis of the biofilms showed upregulation of genes involved in redox metabolism. Additionally, genes involved in mycolic acid, other lipid and glyoxylate metabolism were also upregulated in the early biofilms.
Collapse
|
9
|
Engineering osteogenic microenvironments by combination of multilayers from collagen type I and chondroitin sulfate with novel cationic liposomes. Mater Today Bio 2020; 7:100071. [PMID: 32924006 PMCID: PMC7476072 DOI: 10.1016/j.mtbio.2020.100071] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2020] [Revised: 07/15/2020] [Accepted: 07/16/2020] [Indexed: 11/28/2022] Open
Abstract
Cationic liposomes composed of a novel lipid (N-{6-amino-1-[N-(9Z) -octadec9-enylamino] -1-oxohexan-(2S) -2-yl} -N'- {2- [N, N-bis(2-aminoethyl) amino] ethyl} -2-hexadecylpropandiamide) (OO4) and dioleoylphosphatidylethanolamine (DOPE) possess high amounts of amino groups and are promising systems for lipofection. Moreover, these cationic liposomes can also be used as a polycationic entity in multilayer formation using layer-by-layer technique (LbL), which is a method to fabricate surface coatings by alternating adsorption of polyanions and polycations. Since liposomes are suitable for endocytosis by or fusion with cells, controlled release of their cargo on site is possible. Here, a polyelectrolyte multilayer (PEM) system was designed of chondroitin sulfate (CS) and collagen type I (Col I) by LbL technique with OO4/DOPE liposomes embedded in the terminal layers to create an osteogenic microenvironment. Both, the composition of PEM and cargo of the liposomes were used to promote osteogenic differentiation of C2C12 myoblasts as in vitro model. The internalization of cargo-loaded liposomes from the PEM into C2C12 cells was studied using lipophilic (Rhodamine-DOPE conjugate) and hydrophilic (Texas Red-labeled dextran) model compounds. Besides, the use of Col I and CS should mimic the extracellular matrix of bone for future applications such as bone replacement therapies. Physicochemical studies of PEM were done to characterize the layer growth, thickness, and topography. The adhesion of myoblast cells was also evaluated whereby the benefit of a cover layer of CS and finally Col I above the liposome layer was demonstrated. As proof of concept, OO4/DOPE liposomes were loaded with dexamethasone, a compound that can induce osteogenic differentiation. A successful induction of osteogenic differentiation of C2C12 cells with the novel designed liposome-loaded PEM system was shown. These findings indicate that designed OH4/DOPE loaded PEMs have a high potential to be used as drug delivery or transfection system for implant coating in the field of bone regeneration and other applications.
Collapse
Key Words
- AFM, Atomic force microscopy
- C2C12 myoblasts
- CLSM, Confocal Laser Scanning Microscopy
- CS, chondroitin sulfate
- Col I, Collagen I
- DLS, Dynamic light scattering
- DMEM, Dulbecco’s modified Eagle’s medium
- DOPE, dioleoylphosphatidylethanolamine
- Dex, Dexamethasone
- ECM, Extracellular matrix
- GAG, Glycosaminoglycan
- LbL, Layer-by-Layer technique
- OO4, (N-{6-amino-1-[N-(9Z) -octadec9-enylamino] -1-oxohexan-(2S) -2-yl} -N’- {2- [N, N-bis(2-aminoethyl) amino] ethyl} -2-hexadecylpropandiamide)
- PBS, Phosphate-buffered saline
- PEI, Polyethylenimine
- PEM, Polyelectrolyte multilayer
- SEM, Scanning electron microscopy
- SPR, Surface plasmon resonance
- TEM, Transmission electron microscopy
- WCA, Water contact angle
- cationic lipids
- chondroitin sulfate
- collagen I
- internalization
- osteogenic differentiation
- polyelectrolyte multilayer system
Collapse
|
10
|
Physical and immunological barrier of human primary nasal epithelial cells from non-allergic and allergic donors. World Allergy Organ J 2020; 13:100109. [PMID: 32180893 PMCID: PMC7063333 DOI: 10.1016/j.waojou.2020.100109] [Citation(s) in RCA: 21] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2019] [Revised: 12/04/2019] [Accepted: 02/12/2020] [Indexed: 11/16/2022] Open
Abstract
The epithelial cell-derived cytokine milieu has been discussed as a “master switch” in the development of allergic disease. To understand the role of innate immune response in nasal epithelial cells during allergic inflammation, we created and established a fast and minimally invasive method to isolate and culture human nasal epithelial cells from clinically and immunologically well characterized patients. Human nasal epithelial cells from non-atopic volunteers and from allergic rhinitis patients were compared in respect to their growth, barrier integrity, pattern recognition, receptor expression, and immune responses to allergens and an array of pathogen-associated molecular patterns and inflammasome activators. Cells from nasal scrapings were clearly identified as nasal epithelial cells by staining of pan-Cytokeratin, Cytokeratin-14 and Tubulin. Additionally, Mucin 5AC staining revealed the presence of goblet cells, while staining of tight-junction protein Claudin-1, Occludin and ZO-1 showed the ability of the cells to form a tight barrier. Cells of atopic donors grew slower than cells of non-atopic donors. All nasal epithelial cells expressed TLR1-6 and 9, yet the expression of TLR-9 was lower in cells from allergic rhinitis (AR) donors. Additionally, epithelial cells from AR donors responded with a different TLR expression pattern to stimulation with TLR ligands. TLR-3 was the most potent modulator of cytokine and chemokine secretion in all human nasal epithelial cells (HNECs). The secretion of IL-1β, CCL-5, IL-8, IL-18 and IL-33 was elevated in HNECs of AR donors as compared to cells of non-atopic donors. This was observed in the steady-state (IL-18, IL-33) as well as under stimulation with TLR ligands (IL-18, IL-33, CCL-5, IL-8), aqueous pollen extracts (IL-18, IL-33), or the inflammasome activator Nigericin (IL-1β). In conclusion, nasal epithelial cells of AR donors show altered physical barrier responses in steady-state and in response to allergen stimulation. Cells of AR donors show increased expression of pro-inflammatory and IL-1 family cytokines at baseline and under stimulation, which could contribute to a micromilieu which is favorable for Th2.
Collapse
Key Words
- ALI, Air liquid interphase
- APE, Aqueous pollen extract
- AR, Allergic rhinitis
- Allergic rhinitis
- HDM, House dust mite
- HNEC, Human nasal epithelial cell
- Inflammation
- LPS, Lipopolysaccharide from E. Coli K12 (TLR-4 ligand)
- MyD88, Myeloid differentiation primary response 88
- Nasal epithelium
- PAMP, Pathogen-associated molecular pattern
- PRR, Pattern recognition receptor
- Pattern recognition receptor
- Pollen
- PolyIC, Polyinosinic–polycytidylic acid (TLR-3 ligand)
- SAR, Seasonal allergic rhinitis
- SEM, Scanning electron microscopy
- TER, Transepithelial electrical resistance
- TLR, Toll-like receptor
- TRIF, TIR-domain-containing adapter-inducing interferon-β
Collapse
|
11
|
Ornithodoros ( Ornithodoros) huajianensis sp. nov. (Acari, argasidae), a new tick species from the Mongolian marmot ( Marmota bobak sibirica), Gansu province in China. INTERNATIONAL JOURNAL FOR PARASITOLOGY-PARASITES AND WILDLIFE 2019; 9:209-217. [PMID: 31194100 PMCID: PMC6551375 DOI: 10.1016/j.ijppaw.2019.05.001] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/26/2018] [Revised: 05/05/2019] [Accepted: 05/06/2019] [Indexed: 11/28/2022]
Abstract
A new argasid species, belonging to the subgenus Ornithodoros, namely, Ornithodoros (Ornithodoros) huajianensis was described for the first time based on the females, males and nymphs. The morphological features of each stage in the life cycle are unique, making identification easy, but are similar to other species of the subgenus Ornithodoros. The new species was diagnosed by the broad rectangular tongue and triangular tongue-shaped posterior lip in the male genital apron, a shallow camerostome with definite folds and smaller mammillae with single seta mixed with larger ones in nymph and adults. The new species had been collected from the Mongolian marmots Marmota bobak sibirica in Huajian village, Gulang county, Gansu province, China. Data on the phylogenic position, hosts and geographic distribution are also provided. A novel species of subgenus Ornithodoros is reported from a Mongolia marmot Marmota bobak sibirica in Gansu province, China. Ornithodoros (Ornithodoros) huajianensis n. sp. is described from females, males and nymphs. Partial sequence of 16S rDNA gene groups this species with O. moubata and O. compactus. Sequence divergence of new species from O. moubata 7.0% and from O. compactus.9.5%.
Collapse
|
12
|
Lactobacillus acidophilus ATCC 4356 inhibits biofilm formation by C. albicans and attenuates the experimental candidiasis in Galleria mellonella. Virulence 2016; 6:29-39. [PMID: 25654408 DOI: 10.4161/21505594.2014.981486] [Citation(s) in RCA: 87] [Impact Index Per Article: 10.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022] Open
Abstract
Probiotic strains of Lactobacillus have been studied for their inhibitory effects on Candida albicans. However, few studies have investigated the effect of these strains on biofilm formation, filamentation and C. albicans infection. The objective of this study was to evaluate the influence of Lactobacillus acidophilus ATCC 4356 on C. albicans ATCC 18804 using in vitro and in vivo models. In vitro analysis evaluated the effects of L. acidophilus on the biofilm formation and on the capacity of C. albicans filamentation. For in vivo study, Galleria mellonella was used as an infection model to evaluate the effects of L. acidophilus on candidiasis by survival analysis, quantification of C. albicans CFU/mL, and histological analysis. The direct effects of L. acidophilus cells on C. albicans, as well as the indirect effects using only a Lactobacillus culture filtrate, were evaluated in both tests. The in vitro results showed that both L. acidophilus cells and filtrate were able to inhibit C. albicans biofilm formation and filamentation. In the in vivo study, injection of L. acidophilus into G. mellonella larvae infected with C. albicans increased the survival of these animals. Furthermore, the number of C. albicans CFU/mL recovered from the larval hemolymph was lower in the group inoculated with L. acidophilus compared to the control group. In conclusion, L. acidophilus ATCC 4356 inhibited in vitro biofilm formation by C. albicans and protected G. mellonella against experimental candidiasis in vivo.
Collapse
Key Words
- ATCC, American type culture collection
- BHI, Brain heart infusion
- CFU, colony-forming unit
- Candida albicans
- Galleria mellonella
- HE, hematoxylin-eosin
- Lactobacillus acidophilus
- MRS, Man, Rogosa and Sharpe
- NIH, National Institutes of Health
- PAS, periodic acid-Schiff
- PBS, phosphate buffered saline
- SEM, Scanning electron microscopy
- YNB, Yeast nitrogen base
- biofilm
- candidiasis
- filamentation
- pH, potential hydrogen ion
- probiotic
Collapse
|